Ray Donahue
Affiliations: | Washington State University, Pullman, WA, United States |
Google:
"Ray Donahue"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
DeMaria PJ, Lee-Wisdom K, Donahue RN, et al. (2021) Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer. Journal For Immunotherapy of Cancer. 9 |
Zhao C, Mule M, Martins A, et al. (2021) 540 Baseline mTOR transcriptional signatures in CD8 T cells are associated with immune-related adverse events but not anti-tumor responses in patients receiving immune checkpoint inhibitors Journal For Immunotherapy of Cancer. 9: A570-A570 |
Gatti-Mays ME, Gameiro SR, Ozawa Y, et al. (2020) Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer. Frontiers in Oncology. 10: 581801 |
Del Rivero J, Donahue RN, Marté JL, et al. (2020) A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer. Frontiers in Endocrinology. 11: 490 |
Gatti-Mays ME, Palena C, Gameiro SR, et al. (2020) Abstract OT1-08-01: A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT) Cancer Research. 80 |
Karzai F, VanderWeele D, Madan RA, et al. (2018) Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations. Journal For Immunotherapy of Cancer. 6: 141 |
Madan RA, Turkbey B, Lepone LM, et al. (2017) Abstract LB-059: Neoadjuvant immunotherapy with androgen deprivation therapy (ADT) prior to radiation in prostate cancer: Impact on multiparametric prostate MRI and immune responses Cancer Research. 77 |
Farsaci B, Donahue RN, Grenga I, et al. (2016) Analyses of Pre-therapy Peripheral Immunoscore and Response to Vaccine Therapy. Cancer Immunology Research |
Ager C, Reilley M, Nicholas C, et al. (2016) 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4 |
Donahue RN, Madan RA, Richards J, et al. (2016) Abstract 4901: Short-course enzalutamide reveals immune activating properties in patients with biochemically recurrent prostate cancer Cancer Research. 76: 4901-4901 |